A recent review of studies found that 10.5 people in every 100,000 in Japan experience moyamoya disease at some point in their lives. In South Korea, 16.1 people in every 100,000 experience ...

Patients with moyamoya disease prescribed antiplatelet therapy, tracked through the Korean National Health Insurance Service (NHIS) database, had a significantly lower risk of death than those who ...

Moyamoya disease is defined as a rare idiopathic ... the prevalence and incidence of MMD is comparatively high in Japan, Korea, Taiwan and China, all having higher prevalence and incidence ...

Known to have a prevalence rate of 0.35 to 0.94 per 1,00,000 people, mainly in the areas of Japan and Korea, Moyamoya disease causes the narrowing of key brain arteries, prompting the brain to ...

The child was misdiagnosed and then treated with chemotherapy for a year. Turns out, he has moyamoya disease...a rare blood vessel disorder. Eventually, they found a surgeon who reconstructed the ...

Moyamoya disease is a rare, progressive cerebrovascular illness caused by blocked arteries in the basal ganglia at the base of the brain. In Japanese, moyamoya means ‘puff of smoke,’ and it ...

Moyamoya disease is a rare disease in which a blockage to the carotid artery in your head reduces how much blood can get to your brain. As a result, your body creates tiny blood vessels (called ...